Clinical Trials
7 trialsNCT04644315 2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2 Terminated
NCT03729297 2021-03-12
Cabo ASAP
Radboud University Medical Center
Phase 2 Terminated
NCT00003489 2017-11-21
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00503776 2017-06-20
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT00101075 2017-02-27
Title XELOX FOR SALIVARY GLAND CANCERS
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00062387 2013-06-03
Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00126607 2013-02-28
Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
National Cancer Institute (NCI)
Phase 2 Terminated